Journal of Hematology & Oncology

official impact factor 2.93

This article is part of the supplement: Current trends in leukemia, lymphoma, myeloma and ITP: updates and highlights from ASH 2008

Open Access Meeting report

What's new in the management of chronic lymphocytic leukemia? 2008 ASH Review (New York Medical College, January 31, 2009)

Kami J Maddocks and Thomas S Lin*

Author Affiliations

The Ohio State University, Division of Hematology-Oncology, 320 West 10th Avenue, Columbus, OH 43210, USA

For all author emails, please log on.

Journal of Hematology & Oncology 2009, 2(Suppl 1):I1 doi:10.1186/1756-8722-2-S1-I1

Published: 26 June 2009

First paragraph (this article has no abstract)

The 2008 ASH Annual Meeting featured several important abstracts highlighting advances in the treatment of chronic lymphocytic leukemia (CLL).